Gang Song
Gründer bei Pillar Biosciences, Inc.
Ursprung des Netzwerks ersten Grades von Gang Song
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital Investment Advisory Hong Kong Ltd (ORI Capital) is a venture capital firm in Hong Kong. The firm was founded by Simone Song in 2015. The firm is headquartered in Hong Kong.
13
| Private Company | Investment Managers | 13 |
Pillar Biosciences, Inc.
 Pillar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gang Song
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Hong Kong | College/University | Undergraduate Degree Graduate Degree | |
| The Chinese University of Hong Kong | College/University | Graduate Degree Graduate Degree | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
Sensible Asset Management Ltd.
 Sensible Asset Management Ltd. Investment ManagersFinance Part of Value Partners Group Ltd., Sensible Asset Management Ltd. is a leading asset management firm. The company is based in Hong Kong, Hong Kong. The Chinese company's strategy is value investing, which involves buying stocks that they believe are the most effective investment style for the long run. The company is transparent to investors and provides details about their announcements and circulars. The company warns investors to be vigilant of any fraudulent websites and emails that seek to pass off as the company's website. Sensible Asset Management was founded in 2004. The CEO is Wai Ming Tse. | Investment Managers | President | |
| Claremont Graduate University | College/University | Graduate Degree | |
| NCI INC | Information Technology Services | Corporate Officer/Principal | |
| FULGENT GENETICS, INC. | Medical/Nursing Services | Director/Board Member | |
| Moffitt Technologies Corp. | Director/Board Member | ||
| New Jersey City University | College/University | Undergraduate Degree | |
| UW Graduate School | College/University | Doctorate Degree | |
| CG ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| Translational Research In Oncology | Corporate Officer/Principal | ||
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Director/Board Member | |
| UW Medicine | College/University | Graduate Degree | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Corporate Officer/Principal | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| COWEN INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
RSM Hong Kong
 RSM Hong Kong Miscellaneous Commercial ServicesCommercial Services RSM Hong Kong operates as an accounting and consulting firms. The firm offers audit and assurance, tax services, risk and corporate advisory services, transaction advisory, financial reporting advisory and technology and management consulting. The company was founded in 1975 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
Meritech Capital Partners
 Meritech Capital Partners Investment ManagersFinance Meritech Capital Partners (Meritech Capital) is a venture capital firm founded in 1999 by Mike Gorden, Paul Madera and Rob Ward. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
| The Hong Kong Polytechnic University | College/University | Graduate Degree | |
| Hong Kong Baptist University | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| Washington University in St. Louis | College/University | Graduate Degree | |
| University College London | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal | |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| California Polytechnic State University (San Luis Obispo) | College/University | Graduate Degree | |
SevenOaks Biosystems LLC
 SevenOaks Biosystems LLC Medical SpecialtiesHealth Technology Part of Medline Industries LP (Illinois), SevenOaks Biosystems LLC is a company that develops medical devices. The company is based in Cambridge, MA. The company was founded by Richard Rox Anderson, Sameer A. Sabir. SevenOaks Biosystems was acquired by Medline Industries LP (Illinois) on November 30, 2016. | Medical Specialties | Director/Board Member | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director of Finance/CFO | |
| MYREXIS, INC. | Financial Conglomerates | Director/Board Member | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer | |
| University of Bristol | College/University | Graduate Degree | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Rhapsody Biologics, Inc.
 Rhapsody Biologics, Inc. BiotechnologyHealth Technology Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA. | Biotechnology | Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Chief Executive Officer | |
| GELESIS INC | Biotechnology | Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
| The University of Waterloo | College/University | Undergraduate Degree | |
Deciduous Therapeutics, Inc.
 Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 33 |
| Hong Kong | 8 |
| Vereinigtes Königreich | 8 |
| Kanada | 4 |
| China | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 19 |
| Finance | 7 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 32 |
| Graduate Degree | 12 |
| Undergraduate Degree | 11 |
| Corporate Officer/Principal | 11 |
| Independent Dir/Board Member | 8 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert M. Forrester | 25 |
| James Mulé | 14 |
| Simone Song | 9 |
| Vincent Chang | 4 |
| Eric Lai | 4 |
| Cathy Choi | 4 |
| Mark P. Valadao | 3 |
| Matt Britz | 3 |
| Gillian Zhou | 3 |
| Kenneth Ho | 3 |
| Dicky To | 3 |
| Maggie Wang | 2 |
| Otto Cheung | 2 |
| Edward Tung | 2 |
| James Huang | 2 |
